Dr. Fintelmann is integrated into the Thoracic Cancer Team at Massachusetts General Hospital. His research focuses on improving lung cancer care with advanced imaging techniques and image-guided minimally invasive interventions.
Dr. Fintelmann studies the spectrum of lung cancer imaging manifestations ranging from early diagnosis (lung cancer screening) to advanced disease. Dr. Fintelmann is particularly interested in leveraging quantitative image analysis and machine learning tools to derive morphomic data (body composition metrics) from computed tomography exams obtained as part of routine clinical care to better stratify patients for appropriate therapies. He is part of a multi-disciplinary research team dedicated to furthering the understanding of cancer cachexia.
Dr. Fintelmann believes that lung cancer patients benefit from interventional oncology and is working on furthering the role of minimally invasive image-guided diagnostic and therapeutic procedures. Specifically, he is studying thermal ablation (cryoablation, microwave ablation) and lung biopsies. Ongoing clinical trials in collaboration with the MGH Cancer Center investigate possible synergy between immunotherapy and cryoablation in patients with advanced lung cancer and advanced melanoma (cryoimmunotherapy, cryoimmunology).